Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib and Radiotherapy in High Risk or Locally Advanced BCC
NCT02956889Phase 2Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Oct 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in basal cell carcinoma (BCC), sponsored by Humanitas Research Hospital. Started Oct 2016; status: terminated.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT02956889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956889.